Association between distress and knowledge among parents of autistic children.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 10 05 2019
accepted: 13 09 2019
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 3 4 2020
Statut: epublish

Résumé

Understanding the overall utility of biological testing for autism spectrum disorder (ASD) is essential for the development and integration of biomarkers into routine care. One measure related to the overall utility of biological testing is the knowledge that a person has about the condition he/she suffers from. However, a major gap towards understanding the role of knowledge in overall utility is the absence of studies that have assessed knowledge of autism along with its predictors within a representative sample of families within the context of routine care. The objective of this study was to measure knowledge of ASD among families within the routine care pathway for biological testing in ASD by examining the association between knowledge with potential correlates of knowledge namely sociodemographic factors, parental stress and distress, and time since diagnosis among parents whose child with ASD is undergoing clinical genetic testing. Parents of a child diagnosed with ASD (n = 85, Mage = 39.0, SD = 7.7) participating in an ongoing prospective genomics study completed the ASD Quiz prior to undergoing genetic testing for clinical and research purposes. Parents also completed self-reported measures of stress and distress. Parent stress and distress was each independently correlated with knowledge of ASD, rs ≥ 0.26, ps < 0.05. Stepwise regression analysis revealed a significant model accounting for 7.8% of the variance in knowledge, F (1, 82) = 8.02, p = 0.006. The only factor significantly associated with knowledge was parental distress, β = 0.30, p = 0.006. Parental stress, time since diagnosis, and sociodemographic factors were not significant predictors in this model. We concluded that families require tailored support prior to undergoing genetic testing to address either knowledge gaps or high distress. Ongoing appraisal of the testing process among families of diverse backgrounds is essential in offering optimal care for families undergoing genetic testing.

Identifiants

pubmed: 31557237
doi: 10.1371/journal.pone.0223119
pii: PONE-D-19-13283
pmc: PMC6763195
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0223119

Subventions

Organisme : CIHR
Pays : Canada

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Qual Life Res. 2002 May;11(3):193-205
pubmed: 12074258
Am J Orthopsychiatry. 2006 Oct;76(4):564-75
pubmed: 17209724
J Community Genet. 2015 Oct;6(4):343-9
pubmed: 25666435
Genet Med. 2006 Jul;8(7):448-50
pubmed: 16845278
Ann Lab Med. 2019 May;39(3):299-310
pubmed: 30623622
Patient Educ Couns. 2003 Nov;51(3):267-75
pubmed: 14630383
J Genet Couns. 2016 Feb;25(1):101-11
pubmed: 25983052
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003721
pubmed: 22336791
Clin Chem Lab Med. 2013 Feb;51(2):e19-22
pubmed: 23095201
J Pediatr. 2013 Oct;163(4):1140-6.e2
pubmed: 23910979
Nat Med. 2015 Feb;21(2):185-91
pubmed: 25621899
J Health Psychol. 2008 Oct;13(7):895-905
pubmed: 18809640
BMJ. 1998 Jan 10;316(7125):133-7
pubmed: 9462322
J Autism Dev Disord. 2015 Oct;45(10):3262-75
pubmed: 26066358
Am J Hum Genet. 2010 May 14;86(5):749-64
pubmed: 20466091
Nat Rev Neurosci. 2011 Sep 20;12(10):603-12
pubmed: 21931335
NeuroRx. 2004 Apr;1(2):182-8
pubmed: 15717018
J Child Fam Nurs. 1999 Sep-Oct;2(5):388-90
pubmed: 10795196
Neurobiol Dis. 2010 May;38(2):181-91
pubmed: 18840528
Am J Hum Genet. 2013 Aug 8;93(2):249-63
pubmed: 23849776
Nat Genet. 2017 Jul;49(7):978-985
pubmed: 28504703
Arch Gen Psychiatry. 2011 Jan;68(1):101-9
pubmed: 20819977
J Neurosci. 2010 Aug 11;30(32):10612-23
pubmed: 20702694
Autism. 2016 Jan;20(1):106-15
pubmed: 25948601
BMC Med. 2011 Feb 22;9:18
pubmed: 21342500
Pediatrics. 2007 Nov;120(5):1183-215
pubmed: 17967920
Nat Neurosci. 2017 Apr;20(4):602-611
pubmed: 28263302
NPJ Genom Med. 2016 Aug 3;1:160271-1602710
pubmed: 27525107
J Genet Couns. 2016 Apr;25(2):298-304
pubmed: 26259530
Genet Med. 2008 Jan;10(1):13-8
pubmed: 18197052
J Natl Cancer Inst. 1995 Feb 15;87(4):286-92
pubmed: 7707420
Pediatrics. 2010 Apr;125(4):e727-35
pubmed: 20231187
JAMA. 2015 Sep 1;314(9):895-903
pubmed: 26325558
CMAJ. 2014 Apr 15;186(7):509-19
pubmed: 24418986
Curr Opin Genet Dev. 2012 Jun;22(3):229-37
pubmed: 22463983
BMC Health Serv Res. 2013 Apr 01;13:121
pubmed: 23547654
PLoS One. 2018 Aug 2;13(8):e0201862
pubmed: 30071114

Auteurs

Afiqah Yusuf (A)

Department of Psychiatry, McGill University, Montreal, Quebec, Canada.

Iskra Peltekova (I)

Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Tal Savion-Lemieux (T)

Autism Spectrum Disorders Research Program, Research-Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Jennifer Frei (J)

Autism Spectrum Disorders Research Program, Research-Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Ruth Bruno (R)

Autism Spectrum Disorders Research Program, Research-Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Ridha Joober (R)

Research Program on Psychotic and Neurodevelopmental Disorders, Douglas Mental Health University Institute, Montreal, Quebec, Canada.

Jennifer Howe (J)

The Centre for Applied Genomics, Hospital for Sick Children, Toronto, Ontario, Canada.

Stephen W Scherer (SW)

The Centre for Applied Genomics, Hospital for Sick Children, Toronto, Ontario, Canada.
McLaughlin Centre and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Mayada Elsabbagh (M)

Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Azrieli Centre for Autism Research, Montreal Neurological Institute, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH